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Human parechoviruses (HPeVs) were detected by 
reverse transcription–PCR in 16.1% of 335 stool samples 
from children <6 years of age with enteritis in Salvador, Bra-
zil. Whole genome sequencing of 1 sample showed a novel 
HPeV that has been designated as HPeV8.
T
he human parechovirus (HPeV) species are small, 
nonenveloped RNA viruses that belong to the highly 
diversiﬁ  ed family Picornaviridae (1). HPeV types 1 and 2 
had been known as echoviruses 22 and 23 within the genus 
Enterovirus but were recognized in the early 1990s as an 
independent genus (2). Recognition of clinical relevance is 
increasing after 4 novel types were more recently described 
(3–7).
Seroprevalence studies from different countries indi-
cate that almost the entire human adult population is infect-
ed. Predominantly in infants, HPeVs can cause a variety of 
clinical symptoms, including diarrhea, and respiratory in-
fection (8,9). Recent data point toward substantial involve-
ment in severe conditions, such as meningitis and infant 
sepsis, for which HPeV may constitute the second most 
frequent causative virus after enterovirus in young children 
(10). Different HPeV types may cause different clinical 
diseases (10,11). Unconnected diseases might be caused by 
yet unrecognized HPeVs.
The Study
To identify possibly unrecognized HPeVs, we system-
atically searched for HPeVs in patients in Brazil with enter-
itis. We used stool samples for the study because the related 
enteroviruses are preferentially transmitted through feces. 
Because reverse transcription–PCR (RT-PCR) for the ge-
nus Enterovirus cannot detect HPeVs (9,10), a broad-range 
real-time RT-PCR assay was developed that can detect all 
known parechovirus types. The assay also can detect new 
HPeV types (9).
The study cohort comprised 335 stool samples from 
Brazilian infants and children <6 years of age with acute di-
arrhea, deﬁ  ned as >3 watery stools in the previous 24 hours 
and lasting no longer than 13 days. From February 2006 
through August 2007, children were seen as outpatients or 
were hospitalized at the University Hospital in Salvador de 
Bahia, Brazil, because of severe dehydration. All analyses 
were performed by using an ABI 7500 real-time RT-PCR 
(Applied Biosystems, Foster City, CA, USA) and an ABI 
3100 automated sequencing platform (Applied Biosys-
tems) at the local Infectious Disease Research Laboratory. 
Informed consent was obtained from the mothers of all en-
rolled patients. The study was approved by the institutional 
ethics committee.
We performed RNA extraction and real-time RT-PCR 
as described (9). A total of 16.1% of samples tested posi-
tive for HPeV. Many samples yielded low HPeV RNA con-
centrations indicated by threshold cycles later than 32 in 
real-time RT-PCR.
The viral protein (VP) 1 capsid protein gene has been 
established for molecular typing of HPeV (3). Consensus 
primers for ampliﬁ  cation and sequencing of the VP1 gene 
were developed. Primer sequences were VP1 forward 5′-
CCATARTGYTTRTARAARCCYCT-3′ and VP1 reverse 
5′-CARAAYTCDTGGGGYTCMCARATGG-3′. VP1 RT-
PCR was successful in only 11 of 54 HPeV-positive sam-
ples, consistent with low RNA concentrations in most 
samples. Ten of the 11 sequenced samples were of known 
and well-characterized types (type 1, 7 samples; type 5, 2 
samples; and type 6, 1 sample). These samples were not 
further analyzed. One sample showed a VP1 sequence that 
clustered with none of the known HPeV types in phyloge-
netic analysis (Figure 1). To determine whether this virus 
represented a new type, its complete genome except the ﬁ  rst 
27 nucleotides of the 5′ terminus was ampliﬁ  ed by overlap-
ping PCR fragments, and the full nucleotide sequence was 
determined as described previously (9) (GenBank acces-
sion no. EU716175).
The best matching sequence was HPeV type 4 with 
76.3% aa identity (Table). Lowest aa identity was 69.3% 
between the new sequence and type 5. Genetic identity 
to Ljungan virus, a rodent parechovirus, was only 44.5%, 
comparable to all previously described HPeVs. Phylogenet-
ic segregation from all known HPeVs was obvious not only 
in VP1 but also along the structural proteins VP0 and VP3 
(aa identities with established HPeV types ranges 71.2%–
80.2% in VP0 and 74.1%–80.0% in VP3) (Figure 1).
Nonstructural family Picornaviridae genes are highly 
recombined (1,3,12,13), resulting in a mosaic structure that 
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limits their utility in phylogenetic analysis. This character-
istic also was the case for the whole nonstructural region 
(comprising regions P2 and P3) of the novel virus. It was 
not clearly segregated from that of all other HPeV prototype 
strains, showing closest overall relationship with HPeV type 
1 strain Harris and the HPeV6 prototype strain NII561-2000 
(Figure 1). To identify possible recombination in the P2/3 
region of the novel virus, we conducted Sim Plot analysis 
(http://sray.med.som.jhmi.edu/SCRoftware/simplot) (Figure 
2). We found no clear similarity with any of the established 
HPeV prototype strains. In contrast to other HPeV prototype 
strains, BootScan analysis showed no evidence for recombi-
nation with other prototype strains in the nonstructural gene 
region. However, this analysis could also not exclude recom-
bination with any other HPeV because of the small number 
of HPeV full genome sequences currently available.
The new HPeV lacked a typical RGD (Arg-Gly-Asp) 
aa motif in the VP1 C terminus. This motif has proven im-
portant for HPeV type 1 infectivity, presumably because 
of interaction with cellular receptors (14). Such a motif is 
present in all known HPeV strains except type 3, and some 
researchers have suggested that the latter may use a differ-
ent receptor for cell entry (3,13).
Conclusions
Most HPeV types have been identiﬁ  ed only recently. 
The associated spectrum of diseases is not fully understood 
and probably has been underestimated. Recent data indi-
cate that HPeVs may cause severe clinical conditions, such 
as infant sepsis and meningitis, in addition to acute diarrhea 
(10). Prevalence in young children with diarrhea was >16% 
in previous studies; more important, <8% of meningitis 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 2, February 2009  311 
Figure 1. Evolutionary relationships between known parechoviruses and the new human parechovirus from this study ( shown in boldface). 
Phylogenetic analyses of A) complete viral protein (VP) 1, B) VP0, and C) VP3, and D) the whole nonstructural region (comprising regions 
P2 and P3), were constructed using the Jones-Taylor-Thornton matrix-based substitution model on an amino acid–driven alignment 
(pairwise deletion option). The evolutionary histories were inferred using the neighbor-joining method and are in the units of the number 
of amino acid substitutions per site. Relevant bootstrap values from 500 replicate trees are shown next to the branches. The scale bars 
show the evolutionary distance from each root. Analysis was conducted in MEGA software version 4 (www.megasoftware.net). HPeV 
reference strains are named in full detail; their GenBank accession numbers are not further indicated. Contemporary HPeV1 strain 
BNI-788st accession number was EF051629 and HPeV6 strain BNI-67 accession number was EU022171. The tree was rooted against 
Ljungan virus, a rodent parechovirus (GenBank accession no. EF202833). In the P2/P3 tree, branches to the Ljungan virus node have 
been truncated for space reasons, as indicated by dotted lines.cases showed evidence of HPeV (9–11). The molecular 
ecology of HPeV seems especially relevant in view of their 
diversiﬁ  ed and strain-dependent pathogenesis (10,11).
This report on HPeVs from Brazil conﬁ  rms  their 
global distribution. The level of diversiﬁ  cation between the 
novel parechovirus and established HPeV types is clearly 
higher than the 20% aa distance in the VP1 protein, which 
resembles the distance between serotypes of enteroviruses 
(1,3) and exceeds the deﬁ  nition threshold of HPeV types 
(3). During revision of this report, the virus received the 
designation HPeV8 by the ICTV Picornavirus Study Group 
(www.picornastudygroup.com/types/parechovirus/hpev.
htm). Like HPeV3, HPeV8 lacks the RGD motif; some 
researchers have suggested that HPeV3 may use a differ-
ent receptor than other HPeV types for cell entry (3,13). 
Of all HPeV types, type 3 has been most strongly asso-
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Table. VP1 amino acid identity between sequences of HPeV, Brazil* 
PeV type and strain 1 2 3 4 5 6 7 8 9 10 11 12 13
HPeV1 
 1.  Harris
 2.  BNI-788St 89.6
HPeV2 
 3.  Williamson 78.7 80.0
HPeV3 
 4.  A308-99 71.7 71.7 71.7
 5.  Can82853-01 72.6 72.1 71.7 97.3
HPeV4 
 6.  T75-4077 78.4 74.0 74.8 70.4 71.2
 7.  K251176-02 77.9 77.1 76.5 70.4 70.8 96.6
HPeV5 
 8.  CT86-6760 74.9 74.0 73.0 66.4 66.8 77.6 80.2
 9.  T92-15 74.9 71.4 70.9 65.0 65.5 76.7 77.2 94.8
HPeV6 
 10.  NII561-2000 81.4 78.8 73.5 74.8 75.2 73.2 73.2 71.4 71.9
 11.  VI2177-67 81.4 77.9 73.5 73.5 73.9 73.2 73.2 72.7 73.2 95.7
Novel type 
 12.  BR/217/2006 74.6 75.9 73.7 72.0 72.4 74.1 76.3 72.4 69.3 72.8 72.8
Rodent PeV 
 13.  Ljungan 43.5 43.5 48.0 44.4 44.0 42.9 44.6 42.9 42.4 43.1 43.5 44.5
*HPeV, human parechovirus; PeV, parechovirus; VP1, viral protein 1. Percentage of amino acid identity per site from analysis between sequences is 
shown. All results (%) are based on the pairwise analysis of 13 sequences (pairwise deletion option). Analyses were conducted in MEGA software 
(www.megasoftware.net). There were 297 positions in the final dataset. 
Figure 2. Nucleic acid identity of the new parechovirus with known parechoviruses. The near full-length genome of the new parechovirus 
BR/217/2006 was analyzed with SimPlot software (http://sray.med.som.jhmi.edu/SCRoftware/simplot) using a 600-bp sliding window and 
a step size of 10. Because of partially incomplete 5′ untranslated region (UTR) GenBank reference sequences, an approximate 400 
nucleotides had to be cut from the 5′ end of all genomes. HPeV, human parechovirus. A) Nucleic acid identity, per analysis window, for strain 
BR/217/2006 with prototype strains. Nucleotide positions on x-axis show the center of the window. B) BootScan analysis using the same 
window settings. A bootstrapped phylogenetic analysis was conducted per window along the alignment. Graphs represent the percentage 
(bootstrap values) at which each strain cosegregates phylogenetically in the analysis window with strain BR/217/2006. Prototype strains 
used for comparison are shown in the inserts in each panel. A schematic representation of the parechovirus genome is given on top. Novel Human Parechovirus
ciated with severe neurologic and systemic clinical condi-
tions (10,11,15). The lack of an RGD motif might implicate 
a different cell or tissue tropism for HPeV8 as well. The 
search for unknown HPeVs should be extended to other 
clinical conditions thus far not associated with HPeV.
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